Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Oxymatrine has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Because gut bacteria perform the reduction of oxymatrine to matrine, the composition of that microbiota influences how much conversion happens and how quickly. Anything that shifts the gut community, including probiotic supplementation or recent antibiotics, can therefore shift the alkaloid profile reaching circulation. The direction of that shift has not been quantified for any specific probiotic strain. Read it as a source of variability rather than a benefit.
Sophora flavescens root is intensely bitter and is classically combined with licorice, which is used in that tradition to soften harsh botanicals and improve palatability. The pairing is documented as formulation custom rather than as a measured pharmacological interaction. Licorice carries its own considerations at sustained intake, including effects on potassium and blood pressure. Read the pairing as tradition, not as a demonstrated combination effect.
Both are plant alkaloids taken in concentrated extract form, and both carry meaningful gastrointestinal effects at higher intakes. Stacking two concentrated alkaloids raises the total load on gut tolerance and on hepatic handling without a documented complementary mechanism. Berberine additionally affects gut microbial composition, which matters here because microbiota drive the oxymatrine to matrine conversion. This is a caution about stacking, not a recommended pairing.
Oxymatrine and silymarin appear together in liver-oriented botanical products, largely because both have literature attached to hepatic outcomes. No study has measured the combination against either alone. Silymarin also inhibits several drug-metabolising enzymes in vitro, which is a reason to be careful about stacking with anything else being metabolised hepatically. Count this as market convention with an unmeasured interaction.
Ferulic acid appears alongside oxymatrine in laboratory work, most often as a comparator or co-treatment antioxidant rather than as a demonstrated partner. The two act through different chemistry, one an alkaloid and one a phenolic acid. Any additive antioxidant reading comes from cell and animal systems. There is no human combination data.
Nothing specific on file for Oxymatrine. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 3 we read for Oxymatrine. The full linked list is below.
1 source behind our Oxymatrine verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.